buy-side-equity-resear…
Generate source-backed buy-side equity research memos from a ticker, starting with investment…
Use a Bayesian intrinsic-growth valuation model to evaluate whether a company's market value sufficiently, excessively, or insufficiently prices its real 3-5 year growth. Use when the user asks for Bayesian valuation, intrinsic growth rate, implied growth, growth-hypothesis
$ npx -y skills add haskaomni/serenity-skill --skill bayesian-intrinsic-growth-valuation --agent claude-codeHow it fires
How this skill gets triggered: by you, by Claude, or both.
/bayesian-intrinsic-growth-valuationContext preview
The summary Claude sees to decide when to auto-load this skill.
Use a Bayesian intrinsic-growth valuation model to evaluate whether a company's market value sufficiently, excessively, or insufficiently prices its real 3-5 year growth. Use when the user asks for Bayesian valuation, intrinsic growth rate, implied growth, growth-hypothesis
name: bayesian-intrinsic-growth-valuation description: Use a Bayesian intrinsic-growth valuation model to evaluate whether a company's market value sufficiently, excessively, or insufficiently prices its real 3-5 year growth. Use when the user asks for Bayesian valuation, intrinsic growth rate, implied growth, growth-hypothesis probabilities, FOMO versus fundamentals, or company analysis based on fundamentals, industry cycle, TAM, market share, margin, valuation multiples, and new information.
Do not classify company news as simply bullish or bearish. Translate every company-specific data point into a probability update for future 3-5 year revenue growth, margin, TAM, market share, valuation multiple, and market sentiment.
The goal is to estimate the company's true intrinsic growth speed and compare it with the growth already implied by the current market value.
Treat outputs as research hypotheses, not personalized investment advice. Verify current market cap, price, revenue, margins, filings, guidance, peer multiples, and news from reliable current sources before making time-sensitive claims.
Use whatever the user provides, and clearly mark missing variables that require verification:
For U.S.-listed companies, use SEC filings as the baseline evidence for reported historical fundamentals. `edgartools` can be used to fetch company filings, XBRL financial statements, filing text, insider transactions, ownership filings, and recent 8-K disclosures.
If the environment does not already have it, install with `pip install edgartools` or `uv pip install edgartools`. The import package is `edgar`, not `edgartools`. SEC access requires an identity; set `EDGAR_IDENTITY="Name email@example.com"` in the environment or call `from edgar import set_identity; set_identity("name@example.com")` before requests.
Minimal usage pattern:
from edgar import Company
company = Company("AAPL")
financials = company.get_financials()
income = financials.income_statement()
balance = financials.balance_sheet()
cashflow = financials.cashflow_statement()Use SEC data to anchor:
Do not use SEC data as a substitute for current market data, consensus estimates, forward multiples, TAM estimates, option activity, or real-time price movement. If using edgartools or SEC filings, name the form and filing date, and separate "reported fact" from "analyst/market estimate."
Always frame future 3-5 year revenue CAGR as probabilities across these hypotheses:
| Hypothesis | Label | 3-5Y revenue CAGR | | --- | --- | --- | | H0 | contraction | <0% | | H1 | mature slow growth | 0%-5% | | H2 | steady growth | 5%-12% | | H3 | high-cycle growth | 12%-25% | | H4 | structural breakout | 25%-50% | | H5 | platform expansion | >50% |
Assign initial probabilities to H0-H5 using fundamentals, industry cycle, TAM, historical growth, and competitive position.
Prefer a conservative prior when evidence is incomplete. Do not let market excitement alone justify H4 or H5.
When new information appears, identify which variables it affects:
If information mainly affects market attention, update valuation multiple and FOMO, not intrinsic growth.
Ask how likely the new information is under each growth hypothesis:
Show the update as prior -> likelihood interpretation -> posterior.
Estimate weighted intrinsic 3-5 year revenue CAGR from the posterior probabilities. Use midpoint assumptions unless better evidence is available:
| Hypothesis | Suggested midpoint | | --- | --- | | H0 | -5% | | H1 | 2.5% | | H2 | 8.5% | | H3 | 18.5% | | H4 | 37.5% | | H5 | 60% or scenario-specific |
Report a range, not false precision.
Infer the growth rate embedded in current valuation using market cap or enterpr
Codex skills for translating market information into testable investment research frameworks.
Generate source-backed buy-side equity research memos from a ticker, starting with investment…
Score a stock's current valuation/trend health using the GF-DMA Health Index, combining…
Classify a listed company and its core industry into Juglar fixed-asset investment cycle…
Translate market-moving news into investable alpha hypotheses by mapping observed demand…
Evaluate a stock's valuation using TAM-Adj-PEG, adjusting traditional PEG by growth runway…